This month’s Editor’s Choice article comes from Sharmila Anandasabapathy, MD, FASGE. She highlights the Original Article, “Management of Barrett’s high-grade dysplasia: initial results from a population-based national audit” by Georgina Chadwick, MRCP,  Oliver Groene, PhD, Angelina Taylor, MSc, et al.

This is the first study to use patient level data, rather than self-reported clinical practice, to examine the management of high-grade dysplasia (HGD). The study evaluated 465 cases of HGD evaluated in England’s NHS and showed marked variation in the management of HGD across England.

Endotherapy for Barrett’s has become widely accepted; however, there is still considerable variability in adherence to expert guidelines and in outcomes. In this evaluation of the National Health Service in England, the authors noted that there was considerable variability in the management of HGD in BE patients and the majority of patients who received active treatment for their disease were either (a) discussed at multidiscplinary meetings or (b) managed at higher volume centers. Adherence to Barrett’s practice guidelines varies with the the volume and specialized expertise of the clinical site. This may have implications for quality, outcomes and future reimbursement.

Read the abstract for this article here.

The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.